News/Earnings/Aug 4, 2026, 4:03 PM ET

Gilead Sciences reports fiscal Q2 2026 results: revenue $7.80B, up 10% from a year earlier

Gilead SciencesGILD

Gilead Sciences filed a Form 8-K with the SEC on Aug 4, 2026, 4:03 PM ET, reporting an event dated Aug 4, 2026. It covers Item 2.02 (Results of Operations and Financial Condition); Item 9.01 (Financial Statements and Exhibits). The results cover fiscal Q2 2026 (quarter ended Jun 30, 2026); figures below are from the company's XBRL financial data filed with the SEC.

  • Revenue: $7.80B (+10.2% from $7.08B a year earlier)
  • Operating income: −$10.39B (vs $2.47B a year earlier)
  • Net income: −$10.50B (vs $1.96B a year earlier)
  • Diluted EPS: $-8.45 (vs $1.56 a year earlier)
  • Form 8-K accepted by EDGAR Aug 4, 2026, 4:03 PM ET
  • Accession number 0000882095-26-000028
GILD around the story · hourly24 h reaction ▼ 1.90%
129.37132.79136.21Gilead Sciences reports fiscal Q2 2026 results: revenue $7.80B, up 10% from a year earlier1Jul 31Aug 2Aug 4Aug 6Aug 8
Source
SEC EDGAR
Aug 4, 2026, 4:03 PM ET
Read the original ↗

SEC filing 8-K · accession 0000882095-26-000028 · sec.gov ↗